FDA Vaccine Policy Chief Resigns, Citing Fundamental Disagreements with HHS Secretary Amid Measles Outbreak March 30, 2025
Unraveling Public Health: Dr. Marks Resigns from FDA in Protest Against HHS Secretary Kennedy’s Vaccine Policies March 30, 2025
FDA’s Vaccine Policy Crisis: Peter Marks Resigns Amid Controversy and Leadership Vacuum March 30, 2025
FDA’s Peter Marks Resigns Amid Vaccine Safety Controversy, Sparking Concerns Over Scientific Integrity and Public Health March 29, 2025
Revolutionary RNA-Based Treatment Qfitlia Offers Hope for Hemophilia Patients with Fewer Doses and Enhanced Management March 29, 2025
Revolutionizing Hemophilia Treatment: FDA Approves Qfitlia, a Game-Changing RNA-Based Therapy March 29, 2025
Revolutionizing Hemophilia Treatment: FDA Approves Fitusiran, Offering Hope with Qfitlia March 29, 2025
Revolutionizing Hemophilia Treatment: FDA Approves Innovative RNA-Based Therapy Qfitlia March 29, 2025
